Mir-23b Plays a Critical Role As a Tumor Suppressor miRNA In Multiple Myeloma
2013-01-01 Fulciniti, M; Amodio, N; Bandi, R; Prabhala, Rh; Adamia, S; Calimeri, T; Biamonte, L; Leotta, M; Anderson, Kc; Tassone, P; Munshi, Nc
Targeting oncogenic miR-17-92 primary transcripts by LNA gapmeRs in multiple myeloma: Molecular findings and therapeutic potential
2016-01-01 Eugenio, Morelli; Lavinia, Biamonte; Cinzia, Federico; Maria Teresa Di Martino, ; Amodio, N; Maria Eugenia Gallo Cantafio, ; Niels, M Frandsen; Maria Rita Pitari, ; Daniele, Caracciolo; Annamaria, Gullà; Rossi, Marco; Pierosandro, Tagliaferri; Tassone, Pierfrancesco
Non Homologous End Joining As a New Prognostic Factor and Potential Target in Multiple Myeloma
2014-01-01 Calimeri, T; Caracciolo, D; Samur, Mk; Amodio, N; Cea, M; Cagnetta, A; Fulciniti, M; Adamia, S; Rossi, M; Tai, Y-T; Morabito, F; Minvielle, S; Avet-Loiseau, H Li C; Lazaro, J-B; Anderson, Kc; Shammas, M; Tagliaferri, P; Tassone, P; Munshi, N
Alternative non-homologous end joining DNA repair as therapeutic target in multiple myeloma
2018-01-01 Daniele, Caracciolo; Martina, Montesano; Emanuela, Altomare; Grazia, Consolo; Amodio, N; Maria Teresa Di Martino, ; Rossi, Marco; Cirino, Botta; Eugenio, Morelli; Giada, Juli; Pierosandro, Tagliaferri; Tassone, Pierfrancesco
LNA-Gapmer Antisense Oligonucleotides Targeting the Oncogenic Lncrna MALAT1 Trigger Anti-Multiple Myeloma Activity By Proteasome Blockade
2017-01-01 Amodio, N; Maria Angelica Stamato, ; Giada, Juli; Eugenio, Morelli; Martina, Manzoni; Elisa, Taiana; Rossi, Marco; Mariamena, Arbitrio; Mariateresa, Fulciniti; Nikhil, Munshi; Antonino, Neri; Pierosandro, Tagliaferri; Tassone, Pierfrancesco
Role of homologous end joining in multiple myeloma genetic instability and as a potential prognostic marker
2013-01-01 Calimeri, T; Kemal Samur, M; Amodio, N; Fulciniti, M; Cea, M; Cagnetta, A; Rossi, M; Tay, Yt; Minvielle, S; Avet-loiseau, H; Li, C; Lazaro, Jb; Anderson, Kc; Tagliaferri, P; Tassone, P; Shammas, M; Munshi, Nc.
Sp1 Inhibition Affects Cell Growth and Survival In Waldenstrom’s Macroglobulinemia Through a MYD88-Independent Pathway
2013-01-01 Fulciniti, F; Bandi, R; Amodio, N; Prabhala, Rh; Munshi, M; Xu, L; Yang, Z; Hunter, Z; Anderson, Kc; Treon, Sp; Munshi, Nc
MiR-29b Exerts Anti-Multiple Myeloma Activity by Targeting Key Oncogenic Pathways and Modulating DNA Methylation Profile
2012-01-01 Amodio, N; Di Martino, Mt; Foresta, U; Rossi, M; Leotta, M; Leone, E; Lionetti, M; Gullà, A; D'Aquila, P; Bellizzi, D; Passarino, G; Fabiani, F; Fulciniti, M; Ferrarini, M; Morabito, F; Neri, A; Munshi, Nc; Anderson, Kc; Tagliaferri, P; Tassone, P.
Inhibitor of DNA Binding 2 (ID2) Plays a Key Tumor Suppressor Role in Promoting Oncogenic Transformation in Multiple Myeloma
2018-01-01 Tommaso, Perini; Raphael, Szalat; Mehmet Kemal, Samur; Mariateresa, Fulciniti; Michael, A Lopez; Matthew, Lawlor; Christopher, J Ott; Na, Li; Yan, Xu; Kenneth, Wen; Amodio, N; Eugenio, Morelli; Kenneth, Anderson; Fabio, Ciceri; Nikhil, Munshi
Synthetic miR-22 inhibits alternative non homologous end-joining DNA repair and increases sensitivity to PARP-inhibition in multiple myeloma cells
2016-01-01 Daniele, Caracciolo; Eugenio, Morelli; Maria Teresa Di Martino, ; Daniela, Talarico; Cirino, Botta; Amodio, N; Cinzia, Federico; Emanuela, Altomare; Lavinia, Biamonte; Maria Angelica Stamato, ; Pierosandro, Tagliaferri; Tassone, Pierfrancesco
In vitro and vivo activity against multiple myeloma cells of a novel locked nucleic acid (LNA)-miR-221 inhibitor
2014-01-01 Di Martino, Mt; Gallo Cantafio, Me; Gulla, A; Altomare, E; Morelli, E; Amodio, N; Leone, E; Botta, C; Frandsen, Nm; Tagliaferri, P and Tassone P
Early Hematopoietic Zinc Finger Protein-Zinc Finger Protein 521: A candidate regulator of normal and leukaemic stem cells
2008-01-01 Mega, T; Lupia, M; Mesuraca, M; Amodio, N; Pelaggi, D; Bullinger, L; Schuringa, Jj; Grieco, M; Moore MAS, ; Bond HM and Morrone, G.
GPER activation mitigates cardiotoxicity induced by the anticancer agent doxorubicin
2015-01-01 De Francesco, Em; Rocca, C; Scavello, F; Amelio, D; Rigiracciolo, Dc; Scarpelli, A; Mesiani, G; Amodio, N; Cerra, Mc; Maggiolini, N; Angelone, T
Phosphoproteomic analysis of miR-21 modulation in Th17 cells: Potential implications for multiple myeloma bone disease therapy
2018-01-01 Emanuela, Altomare; Rossi, Marco; Daniele, Caracciolo; Amodio, N; Gaspari, Marco; Domenico, Taverna; Scumaci, Domenica; Cirino, Botta; Annamaria, Gullà; Eugenio, Morelli; Paola, Critelli; Mariamena, Arbitrio; Pierosandro, Tagliaferri; Tassone, Pierfrancesco
Pharmacokinetics and Biodistribution of Locked Nucleic Acid (LNA)-Mir-221 Inhibitor: A New Promising Anti-Myeloma Agent
2015-01-01 Gallo Cantafio, Me; Gullà, A; Amodio, N; Leone, E; Morelli, E; Biamonte, L; Neri, A; Tagliaferri, P; Tassone, P and Di Martino MT
P21-ACTIVATED KINASE 4 (PAK4) REGULATES MULTIPLE MYELOMA (MM) CELL GROWTH AND SURVIVAL BY MODULATION OF CRITICAL TRANSCRIPTIONAL PATHWAYS: THERAPEUTIC APPLICATION OF PAK4 ALLOSTERIC INHIBITORS
2015-01-01 Fulciniti, Mt; Oliva, S; Amodio, N; Roccaro, A; Bandi, Rl; H, Daisy; Cagnetta, A; Senapedis, W; Baloglu, E; Anderson, Kc; Ghobrial, I; Munshi, Nc
Selective Activation of the Non-Classical Estrogen Receptor Gper Elicits Potent Anti-Tumor Activity in Multiple Myeloma
2015-01-01 Amodio, N; Romeo, E; Stamato, Me; Morelli, E; Fulciniti, M; Raimondi, L; Leotta, M; Di Martino, Mt; Tagliaferri, P; Munshi, Nc; and Tassone, P
MYC-MIR-22 REGULATORY LOOP MODULATES LENALIDOMIDE ACTIVITY IN MULTIPLE MYELOMA CELLS
2018-01-01 Caracciolo, D; Montesano, M; Rossi, M; M Di Martino, ; Amodio, N; Altomare, E; Consolo, G; Tagliaferri, P; Tassone, P
Targeting oncogenic miR-17-92 primary transcripts by LNA gapmeRs in multiple myeloma: Molecular findings and therapeutic potential
2016-01-01 Morelli, E; Biamonte, L; Federico, ; Di Martino, Mt; Amodio, N; Gallo Cantafio, Me; Frandsen, Nm; Pitari, Mr; Caracciolo, D; Gullà, A; Rossi, M; Tagliaferri P and Tassone, P.
Different myocardial and coronary actions of two red wine flavonoids: Quercetin and Myricetin
2009-01-01 Angelone, T; Di Majo, D; Pasqua, T; Quintieri, A; Filice, E; Vitelli, R; Amodio, N; Tota, B; Giammanco, M; Cerra, Mc.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Mir-23b Plays a Critical Role As a Tumor Suppressor miRNA In Multiple Myeloma | 1-gen-2013 | Fulciniti, M; Amodio, N; Bandi, R; Prabhala, Rh; Adamia, S; Calimeri, T; Biamonte, L; Leotta, M; Anderson, Kc; Tassone, P; Munshi, Nc | |
| Targeting oncogenic miR-17-92 primary transcripts by LNA gapmeRs in multiple myeloma: Molecular findings and therapeutic potential | 1-gen-2016 | Eugenio, Morelli; Lavinia, Biamonte; Cinzia, Federico; Maria Teresa Di Martino, ; Amodio, N; Maria Eugenia Gallo Cantafio, ; Niels, M Frandsen; Maria Rita Pitari, ; Daniele, Caracciolo; Annamaria, Gullà; Rossi, Marco; Pierosandro, Tagliaferri; Tassone, Pierfrancesco | |
| Non Homologous End Joining As a New Prognostic Factor and Potential Target in Multiple Myeloma | 1-gen-2014 | Calimeri, T; Caracciolo, D; Samur, Mk; Amodio, N; Cea, M; Cagnetta, A; Fulciniti, M; Adamia, S; Rossi, M; Tai, Y-T; Morabito, F; Minvielle, S; Avet-Loiseau, H Li C; Lazaro, J-B; Anderson, Kc; Shammas, M; Tagliaferri, P; Tassone, P; Munshi, N | |
| Alternative non-homologous end joining DNA repair as therapeutic target in multiple myeloma | 1-gen-2018 | Daniele, Caracciolo; Martina, Montesano; Emanuela, Altomare; Grazia, Consolo; Amodio, N; Maria Teresa Di Martino, ; Rossi, Marco; Cirino, Botta; Eugenio, Morelli; Giada, Juli; Pierosandro, Tagliaferri; Tassone, Pierfrancesco | |
| LNA-Gapmer Antisense Oligonucleotides Targeting the Oncogenic Lncrna MALAT1 Trigger Anti-Multiple Myeloma Activity By Proteasome Blockade | 1-gen-2017 | Amodio, N; Maria Angelica Stamato, ; Giada, Juli; Eugenio, Morelli; Martina, Manzoni; Elisa, Taiana; Rossi, Marco; Mariamena, Arbitrio; Mariateresa, Fulciniti; Nikhil, Munshi; Antonino, Neri; Pierosandro, Tagliaferri; Tassone, Pierfrancesco | |
| Role of homologous end joining in multiple myeloma genetic instability and as a potential prognostic marker | 1-gen-2013 | Calimeri, T; Kemal Samur, M; Amodio, N; Fulciniti, M; Cea, M; Cagnetta, A; Rossi, M; Tay, Yt; Minvielle, S; Avet-loiseau, H; Li, C; Lazaro, Jb; Anderson, Kc; Tagliaferri, P; Tassone, P; Shammas, M; Munshi, Nc. | |
| Sp1 Inhibition Affects Cell Growth and Survival In Waldenstrom’s Macroglobulinemia Through a MYD88-Independent Pathway | 1-gen-2013 | Fulciniti, F; Bandi, R; Amodio, N; Prabhala, Rh; Munshi, M; Xu, L; Yang, Z; Hunter, Z; Anderson, Kc; Treon, Sp; Munshi, Nc | |
| MiR-29b Exerts Anti-Multiple Myeloma Activity by Targeting Key Oncogenic Pathways and Modulating DNA Methylation Profile | 1-gen-2012 | Amodio, N; Di Martino, Mt; Foresta, U; Rossi, M; Leotta, M; Leone, E; Lionetti, M; Gullà, A; D'Aquila, P; Bellizzi, D; Passarino, G; Fabiani, F; Fulciniti, M; Ferrarini, M; Morabito, F; Neri, A; Munshi, Nc; Anderson, Kc; Tagliaferri, P; Tassone, P. | |
| Inhibitor of DNA Binding 2 (ID2) Plays a Key Tumor Suppressor Role in Promoting Oncogenic Transformation in Multiple Myeloma | 1-gen-2018 | Tommaso, Perini; Raphael, Szalat; Mehmet Kemal, Samur; Mariateresa, Fulciniti; Michael, A Lopez; Matthew, Lawlor; Christopher, J Ott; Na, Li; Yan, Xu; Kenneth, Wen; Amodio, N; Eugenio, Morelli; Kenneth, Anderson; Fabio, Ciceri; Nikhil, Munshi | |
| Synthetic miR-22 inhibits alternative non homologous end-joining DNA repair and increases sensitivity to PARP-inhibition in multiple myeloma cells | 1-gen-2016 | Daniele, Caracciolo; Eugenio, Morelli; Maria Teresa Di Martino, ; Daniela, Talarico; Cirino, Botta; Amodio, N; Cinzia, Federico; Emanuela, Altomare; Lavinia, Biamonte; Maria Angelica Stamato, ; Pierosandro, Tagliaferri; Tassone, Pierfrancesco | |
| In vitro and vivo activity against multiple myeloma cells of a novel locked nucleic acid (LNA)-miR-221 inhibitor | 1-gen-2014 | Di Martino, Mt; Gallo Cantafio, Me; Gulla, A; Altomare, E; Morelli, E; Amodio, N; Leone, E; Botta, C; Frandsen, Nm; Tagliaferri, P and Tassone P | |
| Early Hematopoietic Zinc Finger Protein-Zinc Finger Protein 521: A candidate regulator of normal and leukaemic stem cells | 1-gen-2008 | Mega, T; Lupia, M; Mesuraca, M; Amodio, N; Pelaggi, D; Bullinger, L; Schuringa, Jj; Grieco, M; Moore MAS, ; Bond HM and Morrone, G. | |
| GPER activation mitigates cardiotoxicity induced by the anticancer agent doxorubicin | 1-gen-2015 | De Francesco, Em; Rocca, C; Scavello, F; Amelio, D; Rigiracciolo, Dc; Scarpelli, A; Mesiani, G; Amodio, N; Cerra, Mc; Maggiolini, N; Angelone, T | |
| Phosphoproteomic analysis of miR-21 modulation in Th17 cells: Potential implications for multiple myeloma bone disease therapy | 1-gen-2018 | Emanuela, Altomare; Rossi, Marco; Daniele, Caracciolo; Amodio, N; Gaspari, Marco; Domenico, Taverna; Scumaci, Domenica; Cirino, Botta; Annamaria, Gullà; Eugenio, Morelli; Paola, Critelli; Mariamena, Arbitrio; Pierosandro, Tagliaferri; Tassone, Pierfrancesco | |
| Pharmacokinetics and Biodistribution of Locked Nucleic Acid (LNA)-Mir-221 Inhibitor: A New Promising Anti-Myeloma Agent | 1-gen-2015 | Gallo Cantafio, Me; Gullà, A; Amodio, N; Leone, E; Morelli, E; Biamonte, L; Neri, A; Tagliaferri, P; Tassone, P and Di Martino MT | |
| P21-ACTIVATED KINASE 4 (PAK4) REGULATES MULTIPLE MYELOMA (MM) CELL GROWTH AND SURVIVAL BY MODULATION OF CRITICAL TRANSCRIPTIONAL PATHWAYS: THERAPEUTIC APPLICATION OF PAK4 ALLOSTERIC INHIBITORS | 1-gen-2015 | Fulciniti, Mt; Oliva, S; Amodio, N; Roccaro, A; Bandi, Rl; H, Daisy; Cagnetta, A; Senapedis, W; Baloglu, E; Anderson, Kc; Ghobrial, I; Munshi, Nc | |
| Selective Activation of the Non-Classical Estrogen Receptor Gper Elicits Potent Anti-Tumor Activity in Multiple Myeloma | 1-gen-2015 | Amodio, N; Romeo, E; Stamato, Me; Morelli, E; Fulciniti, M; Raimondi, L; Leotta, M; Di Martino, Mt; Tagliaferri, P; Munshi, Nc; and Tassone, P | |
| MYC-MIR-22 REGULATORY LOOP MODULATES LENALIDOMIDE ACTIVITY IN MULTIPLE MYELOMA CELLS | 1-gen-2018 | Caracciolo, D; Montesano, M; Rossi, M; M Di Martino, ; Amodio, N; Altomare, E; Consolo, G; Tagliaferri, P; Tassone, P | |
| Targeting oncogenic miR-17-92 primary transcripts by LNA gapmeRs in multiple myeloma: Molecular findings and therapeutic potential | 1-gen-2016 | Morelli, E; Biamonte, L; Federico, ; Di Martino, Mt; Amodio, N; Gallo Cantafio, Me; Frandsen, Nm; Pitari, Mr; Caracciolo, D; Gullà, A; Rossi, M; Tagliaferri P and Tassone, P. | |
| Different myocardial and coronary actions of two red wine flavonoids: Quercetin and Myricetin | 1-gen-2009 | Angelone, T; Di Majo, D; Pasqua, T; Quintieri, A; Filice, E; Vitelli, R; Amodio, N; Tota, B; Giammanco, M; Cerra, Mc. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista896
Data di pubblicazione
- 2020 - 202544
- 2010 - 2019475
- 2000 - 2009324
- 1990 - 199951
- 1987 - 19892
Editore
- IOS PRESS, NIEUWE HEMWEG 6B, 11
- Pacini Editore Medicina1
Rivista
- NEUROLOGICAL SCIENCES93
- DIGESTIVE AND LIVER DISEASE51
- INTERNAL AND EMERGENCY MEDICINE28
- JOURNAL OF ENDOCRINOLOGICAL INVES...27
- CIRCULATION24
- BLOOD18
- EPILEPSIA18
- EUROPEAN HEART JOURNAL18
- DIGESTIVE AND LIVER DISEASE. SUPP...17
- ANNALI ITALIANI DI MEDICINA INTERNA14
Keyword
- amino acid radiopharmaceuticals6
- breast cancer3
- glioma3
- PET3
- : toxic and essential metals1
- acufeni1
- Adolescents1
- Anger rumination1
- Anxiety in Children's mothers1
- bariatric surgery1
Lingua
- eng519
- ita58
- fre1
- und1
Accesso al fulltext
- no fulltext896